For paclitaxel we found that three genes were reported to be associated with ovarian cancer (HOXB2, MYC, and TFPI2; p=0.024) and two genes were strongly associated with tumorigenesis of breast cancer (DUSP2 and ITGA3; p<0.001) [29–31]. Here, TFPI2 is linked to breast carcinoma.